Skip to content

Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.

The Study of Outpatient Ketogenic Diet on Seizure Rate, Nutritional Status and Some Biochemical Factors in Children and Adolescent With Refractory Epilepsy.

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03031028
Enrollment
30
Registered
2017-01-25
Start date
2016-07-31
Completion date
2017-03-31
Last updated
2017-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Epilepsy

Keywords

refractory epilepsy,, ketogenic diet, classic ketogenic diet, seizure rate, efficacy, epilepsy

Brief summary

This study will consider the effectiveness of the ketogenic diet (high-fat, low-carbohydrate, and moderate protein) in treating epilepsy. Investigators enroll a group of eligible epileptic children and adolescent who have been referred from epilepsy center to our clinic and prescribe them ketogenic diet.

Detailed description

This research will be done to observe efficacy, safety, and tolerability of the classic ketogenic diet (CKD) on an outpatient basis without fasting, caloric and fluid restriction in children with and adolescents with intractable epilepsy. 30 children and adolescents with intractable epilepsy based on inclusion and exclusion criteria have been enrolled in the study, Investigators prescribe them classic ketogenic diet. Efficacy of the diet will be assessed through seizure rates, number of anti-epileptic drug used by the patients, and EEG changes. Seizure frequency will be assessed by seizure record diary that is filled out by family of the patients and will be compared with data that will be taken at 1, 3 months after start of the diet. EEG will be taken at baseline and 3 months after start of the diet. Patients will be reviewed at 1, 3 months after start of the diet at outpatient clinic. Intolerances and Complications will be documented at each clinic visits and via telephone calling during clinic visits intervals to evaluate tolerability and safety of the KD. For close monitoring of the complications along with blood tests and urinalysis Investigators will do echocardiography and renal ultrasound at baseline and 3 months after start of the diet. Laboratory values will be assessed at baseline and 3 months after start of the diet. Also, nutritional status and growth of children will be assessed at baseline and 1, 3 months after start of diet.

Interventions

OTHERketogenic diet

Ketogenic Diet is a high fat, low carbohydrate diet.

Sponsors

Tehran University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Ages 1-18 years, * The patient has tried at least 3 different AED:s including one combination with two or more different AED:s. * The parents are willing to include their child in the study after written and verbal information. * Patients with all types of epilepsy can be included. * The patient is submitted to our epilepsy center.

Exclusion criteria

* The patient has a medical condition, for example a metabolic disease, where ketogenic diet is contraindicated. * The patient's nutritional status is not good enough or intake of fluid is to small to permit treatment with ketogenic diet. * No history of hyperlipidemia * No history of renal stones * No previous treatment with ketogenic diet * Beta-oxidation defects - medium-chain acyl dehydrogenase deficiency (MCAD), long-chain acyl dehydrogenase deficiency (LCAD), short-chain acyld dehydrogenase deficiency (SCAD), long-chain 3-hydroxyacyl-coenzyme A (CoA) deficiency, and medium-chain 3- hydroxyacyl-CoA deficiency. * The family is expected to have compliance problems with treatment and/or seizure registration

Design outcomes

Primary

MeasureTime frameDescription
seizure rate3 monthsThe information will be obtained through seizure diary

Secondary

MeasureTime frameDescription
HeightBefore and after 1 and 3 months on the classical KD.Height of the participants will be assessed by stadiometer and Unit for height is cm.
serum TriglycerideBefore and after 3 months on the classical KDserum Triglyceride will be assessed. Units for serum TG, is mg/dl.
WeightBefore and after 1 and 3 months on the classical KD.Weight of the participants will be assessed by seca scale and Unit for weight is kilogram.
Investigating side effectsAfter 3 months on the classical KDSide effects will be obtained via parents' reports.
serum LDL-CholesterolBefore and after 3 months on the classical KD.serum LDL-Cholesterol will be assessed. Units for serum LDL-C is mg/dL.
serum HDL-CholesterolBefore and after 3 months on the classical KDserum HDL-Cholesterol will be assessed. Units for serum HDL-C is mg/dL
serum Cholesterol,Before and after 3 months on the classical KDserum Cholesterol will be assessed. Units for serum Cholesterol is mg/dL.

Countries

Iran

Contacts

Primary ContactMaryam Mahmoudi, MD, PHD
m-mahmoudi@sina.tums.ac.ir00989126182883
Backup ContactMona Kavoosi, MSc student
m_kavoosi@razi.tums.ac.ir00989123759711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026